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The efficacies of colicins E1 and N against Escherichia coli strains responsible for postweaning diarrhea and
edema disease, two of the most prevalent disease problems for pigs in the United States, were determined in
vitro. These proteins may provide an environmentally sound means for the prevention of these infections in
swine.
Postweaning diarrhea and edema disease, caused by Esche-
richia coli infections, are two of the most prevalent disease
problems for pigs in the United States (12). More than 43% of
the large swine facilities in the United States reported E. coli
infections among weaned pigs in 2000, and in an attempt to
prevent the spread of these infections, more than 78% of these
facilities reported using prophylactic antibiotic treatments
(12). The strains considered primarily responsible for these
infections, F4 (K88) and F18, are not well controlled by tradi-
tional prophylactic antibiotic treatments due to the frequency
and spectrum of antibiotic resistance seen in these strains (2, 8)
and therefore still cause substantial losses to producers, due to
both mortality and morbidity. With worldwide concern over
the use of prophylactic antibiotics in animal agriculture and
their contribution to the spread of antibiotic resistance (3, 4,
13), the development of alternatives to conventional antibiotics
is urgently needed to protect swine from these E. coli infec-
tions.
Colicins, a class of bacteriocins produced by, and effective
against, E. coli and closely related species (5), hold particular
promise as alternatives to conventional antibiotics used for the
control of postweaning diarrhea and edema disease in pigs.
Studies examining the antibacterial activity of different colicins
have typically yielded qualitative rather than quantitative de-
termination of activity by using direct spotting or overlay tech-
niques to determine efficacy (6, 10, 11). However, in this study,
we quantitatively compared the efficacy of two purified colicins
(colicins E1 [ColE1] and N [ColN]) in inhibiting the growth of
the E. coli strains responsible for postweaning diarrhea and
edema disease.
Purified colicins were obtained by inoculating colicin-pro-
ducing E. coli strains (NC50132 and NC50145) obtained from
the National Collection of Type Cultures (Public Health Lab-
oratory Service, London, England) into Luria Broth (LB) to a
starting optical density at 600 nm (OD600) of about 0.1 and
incubating the cultures with shaking at 37°C. Colicin produc-
tion was induced when cultures reached an OD600 of 0.9 by the
addition of 0.2 U of mitomycin C (Sigma)/ml of culture. The
cell-free supernatant was obtained by centrifugation 5.5 h later
and concentrated by ultrafiltration across a regenerated cellu-
lose membrane in a stir cell apparatus (Amicon, Millipore,
Bedford, Mass.). The concentrated sample was then desalted
against 10 mM Tris-Cl, pH 8, and purified by ion exchange
chromatography using Q Sepharose (Amersham Biosciences,
Piscataway, N.J.) equilibrated with 10 mM Tris-Cl, pH 8. The
bound protein was eluted with a continuous NaCl gradient by
using an AKTAprime chromatography system (Amersham
Bioscience), and fractions containing the highest concentra-
tions of colicin were pooled and concentrated by ultrafiltration.
The protein concentrations of these pooled samples were de-
termined (9), and the percentage of colicin was determined by
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FIG. 1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
of purified ColE1 and ColN. Lane 1, BenchMark prestained protein
ladder (Invitrogen, Carlsbad, Calif.); lane 2, 5 g of the purified ColE1













densitometry after sodium dodecyl sulfate-polyacrylamide gel
electrophoresis followed by Coomassie blue staining with a
16-bit megapixel charge-coupled device camera, FluorChem
8800, and FluorChem IS800 software (Alpha Innotech, San
Leandro, Calif.). Yields of 1.1 mg of purified ColN/liter of
culture and 7.6 mg of purified ColE1/liter of culture were
obtained. The purity of the ColN and ColE1 isolates were 30
and 85%, respectively (Fig. 1).
Quantitative determinations of the efficacies of these puri-
fied colicins against E. coli F4 (K88) and F18 were made by
using pure cultures obtained from the culture collection at the
USDA Agricultural Research Service Federal Food Safety Re-
search Unit (College Station, Tex.). These cultures were grown
overnight in LB at 37°C with shaking and then used to inocu-
late a flask of LB to an OD600 of about 0.05. The freshly
inoculated LB was then aliquoted (5 ml) into culture tubes
containing various colicin concentrations (Fig. 2 and 3). The
volume of the colicin addition was made constant (175 l) with
10 mM Tris, pH 8. These tubes were then incubated with
shaking at 37°C, and their OD600 was determined hourly for
6 h. The CFU/milliliter of these E. coli strains were also de-
termined by serial dilutions and direct plating on LB, both
initially and 3 h postinoculation. These experiments were re-
peated in triplicate, and the values presented are means. ColN
was more effective (P  0.05) than ColE1 against E. coli F4
(K88). Tenfold more ColE1 than ColN was required to inhibit
the growth of E. coli F4 (K88) (Fig. 2 and 3). After 3 h of
growth in LB containing 50 g of colicin/ml, ColN caused a
2-log reduction in CFU/milliliter, whereas ColE1 caused only a
1-log reduction (Table 1). ColE1, however, was far more ef-
fective (P  0.05) than ColN against E. coli F18 (Fig. 2 and 3).
No increase in the OD600 was seen during the 6-h incubation
with 1 g of ColE1/ml, whereas ColN concentrations greater
than 25 g/ml were needed to see this effect. Both 1 g of
ColE1 and 50 g of ColN/ml caused a 1-log reduction in the
CFU of E. coli F18/milliliter (Table 1).
The prophylactic use of antibiotics in animal agriculture has
been greatly scrutinized in recent years due to concerns re-
garding its role in contributing to antibiotic resistance. This
scrutiny has led to increased regulation over the use of antibi-
otics in animal agriculture (3, 4, 13) and will likely continue
towards zero tolerance for the use of prophylactic or growth-
FIG. 2. Effect of ColE1 on the growth of E. coli F4 (K88) (a) and F18 (b).
FIG. 3. Effect of ColN on the growth of E. coli F4 (K88) (a) and F18 (b).
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promoting antibiotic use in animals. Therefore, it is essential
for the sustainability of animal agriculture to examine alterna-
tives to conventional antibiotics to improve animal health and
production efficiency. Because of their in vitro efficacy against
E. coli F4 (K88) and F18, the strains responsible for causing
postweaning diarrhea and edema disease in pigs, ColE1 and
ColN should be examined as alternatives to conventional an-
tibiotics in swine production. Since the modes of cell recogni-
tion and transport through the periplasm are dramatically dif-
ferent between ColE1 and ColN (1, 7), a combination of these
colicins may be more effective than either colicin alone for
their use in animal agriculture.
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TABLE 1. Effect of colicins on the viability of E. coli F4 (K88) and








F4 (K88) 0 3 109 0 3 109
50 5 106 10 1.1 107
200 4 106 50 6 105
F18 0 2 109 0 2 109
1 1.2 106 50 1 106
100 5 104 100 4 105
a Initial CFU/milliliter were 6  107 and 1  107 for E. coli F4 (K88) and F18,
respectively.
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